The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and http://PharmExec.com to bring the latest commercial insights to ...
The Future of Fertility: AI, Personalized Medicine, and Ethical Considerations
In this episode of the Pharmaceutical Executive podcast, Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility (@md.lawrence.werlin on TikTok), discusses the challenges of addressing fertility misinformation on social media. He emphasizes the importance of providing accurate and reliable information and encourages patients to consult with healthcare professionals. He also discusses the ethical considerations of using social media to share personal and professional experiences in the field of fertility and so much more!
--------
30:12
Key Findings of the NIAGARA and HIMALAYA Trials
In this episode of the Pharmaceutical Executive podcast, Shubh Goel, Head of Immuno-Oncology and Gastrointestinal Tumors, US Oncology Business Unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer, and much more.
--------
13:20
Fake Weight Loss Drugs: Growing Threat to Consumer Health
UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss:
Counterfeit weight loss drugs (particularly fake Ozempic) and potential health risks
What can be done to raise awareness among consumers about the dangers of counterfeit medications
Ways increase access to legitimate weight loss medications, especially for those in underserved communities
and much more!
--------
21:15
A Different Approach to Dermatology Care
Brian Hillberdink, EVP, LEO Pharma and President of LEO Pharma's US affiliate, discusses how is they're positioning to capitalize on the unmet needs in other specific therapeutic areas, their approach to orphan drug development, challenges and opportunities adapting to the US market, and more.
--------
14:52
Beyond the Birthrate: The Societal Costs of Maternal Morality
In this episode of the Pharmaceutical Executive podcast, Charlotte Owens, MD, FACOG, Head of Medical Affairs and Outcomes Research at Organon discusses:
The broader societal implications of these maternal health issues highlighted in The Commonwealth Fund study
The most critical changes needed to close the gaps in R&D for maternal health solutions and how feasible they are to make
Specific efforts Organon is undertaking to invest in research, education, and its pipeline to focus on critical areas of need in maternal health
How her in-practice experience as an OB-GYN are informing Organon's strategic approach to addressing maternal health challenges
and more!
The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and http://PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry.
Italia